I reiterate a buy on Procter & Gamble for its fortress dividend and defensive income profile, not near-term growth. PG's FY2026 delivered resilient cash flow and a 100% free cash flow conversion, even
Procter & Gamble NYSE: PG reported fiscal 2026 results within its initial guidance ranges, as modest organic sales growth, a 1% increase in core earnings per share and more than $15 billion returned t

Procter & Gamble reported quarterly earnings per share that topped Wall Street's estimates, but its revenue fell short of expectations. P&G also announced that CEO Shailesh Jejurikar will become chair
Markets face a pivotal week with the Fed, Core PCE, GDP and earnings from Microsoft, Meta, Apple and Amazon all set to drive trading sentiment.
Wall Street faces one of its busiest weeks of the summer, with earnings from four of the Magnificent Seven companies, the Federal Reserve's latest policy decision, and key inflation data all set to te
Procter & Gamble remains a Hold, as I see muted upside due to its premium valuation and inconsistent performance versus the S&P 500. PG's recent acceleration in top and bottom-line growth is encouragi